Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study

Microstructural Changes of the Human Brain from Early to Mid-Adulthood

(2017) Lixia Tian et al.   Frontiers in Human Neuroscience

Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients

(2017) Qi Wu et al.   JOURNAL OF IMMUNOLOGY

Gray Matter Atrophy Is Primarily Related to Demyelination of Lesions in Multiple Sclerosis: A Diffusion Tensor Imaging MRI Study

(2017) Eszter Tóth et al.   Frontiers in Neuroanatomy

Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis

(2016) R. Zivadinov et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Neuroinflammatory component of gray matter pathology in multiple sclerosis

(2016) Elena Herranz et al.   ANNALS OF NEUROLOGY

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Adaptive regulation of the brain’s antioxidant defences by neurons and astrocytes

(2016) Paul S. Baxter et al.   FREE RADICAL BIOLOGY AND MEDICINE

Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients

(2016) Niels Bergsland et al.   Multiple Sclerosis Journal

Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine

(2016) Robert Zivadinov et al.   Expert Review of Neurotherapeutics

Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients

(2016) Niels Bergsland et al.   Multiple Sclerosis Journal

Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study

(2015) Alvino Bisecco et al.   HUMAN BRAIN MAPPING

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study

(2015) D. H. Miller et al.   NEUROLOGY

Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro

(2015) Melanie S. Brennan et al.   PLoS One

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

(2014) Douglas L. Arnold et al.   JOURNAL OF NEUROLOGY

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

(2014) Douglas L. Arnold et al.   JOURNAL OF NEUROLOGY

Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome

(2014) Roberto Cappellani et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Permutation inference for the general linear model

(2014) Anderson M. Winkler et al.   NEUROIMAGE

Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years

(2013) R. Zivadinov et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients

(2013) Ralph HB Benedict et al.   Multiple Sclerosis Journal

The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects

(2013) A. Minagar et al.   NEUROLOGY

Gray matter damage predicts the accumulation of disability 13 years later in MS

(2013) M. Filippi et al.   NEUROLOGY

Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis

(2013) Robert Zivadinov et al.   RADIOLOGY

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis

(2011) Rose Gelineau-Morel et al.   HUMAN BRAIN MAPPING

A Bayesian model of shape and appearance for subcortical brain segmentation

(2011) Brian Patenaude et al.   NEUROIMAGE

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis

(2011) Robert Zivadinov et al.   NEUROIMAGE

Oral Therapies for Multiple Sclerosis

(2010) Ralf Gold   CNS DRUGS

A reproducible evaluation of ANTs similarity metric performance in brain image registration

(2010) Brian B. Avants et al.   NEUROIMAGE

Extent of cerebellum, subcortical and cortical atrophy in patients with MS

(2009) Deepa Preeti Ramasamy et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Connecting white matter injury and thalamic atrophy in clinically isolated syndromes

(2009) Roland G. Henry et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Regional grey matter atrophy in clinically isolated syndromes at presentation

(2008) R G Henry et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord

(2008) C P Gilmore et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

(2008) Ludwig Kappos et al.   LANCET